Free Trial
NASDAQ:OM

Outset Medical (OM) Stock Price, News & Analysis

Outset Medical logo
$17.95 -0.52 (-2.82%)
Closing price 05/23/2025 04:00 PM Eastern
Extended Trading
$18.52 +0.57 (+3.20%)
As of 05/23/2025 05:22 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Outset Medical Stock (NASDAQ:OM)

Key Stats

Today's Range
$17.54
$18.54
50-Day Range
$8.28
$19.58
52-Week Range
$5.85
$72.60
Volume
112,546 shs
Average Volume
105,565 shs
Market Capitalization
$318.11 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$27.00
Consensus Rating
Buy

Company Overview

Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also provides Tablo Data Ecosystem, including TabloHub, a customer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.

Outset Medical Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
27th Percentile Overall Score

OM MarketRank™: 

Outset Medical scored higher than 27% of companies evaluated by MarketBeat, and ranked 796th out of 918 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Outset Medical has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    Outset Medical has only been the subject of 2 research reports in the past 90 days.

  • Read more about Outset Medical's stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Outset Medical is -7.24, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Outset Medical is -7.24, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Outset Medical has a P/B Ratio of 7.33. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Outset Medical's valuation and earnings.
  • Percentage of Shares Shorted

    32.00% of the float of Outset Medical has been sold short.
  • Short Interest Ratio / Days to Cover

    Outset Medical has a short interest ratio ("days to cover") of 9.3.
  • Change versus previous month

    Short interest in Outset Medical has recently increased by 9.80%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Outset Medical does not currently pay a dividend.

  • Dividend Growth

    Outset Medical does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    32.00% of the float of Outset Medical has been sold short.
  • Short Interest Ratio / Days to Cover

    Outset Medical has a short interest ratio ("days to cover") of 9.3.
  • Change versus previous month

    Short interest in Outset Medical has recently increased by 9.80%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Outset Medical has a news sentiment score of 1.15. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.75 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for Outset Medical this week, compared to 5 articles on an average week.
  • Search Interest

    Only 1 people have searched for OM on MarketBeat in the last 30 days. This is a decrease of -67% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Outset Medical insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $38,591.00 in company stock.

  • Percentage Held by Insiders

    Only 2.40% of the stock of Outset Medical is held by insiders.

  • Read more about Outset Medical's insider trading history.
Receive OM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Outset Medical and its competitors with MarketBeat's FREE daily newsletter.

OM Stock News Headlines

Memorial Day Sale! 82% Off Disruptors and Dominators!
Jensen Huang recently gave the keynote speech at the Consumer Electronics Show in Las Vegas. When the Nvidia CEO walked on stage, you could've heard a pin drop. Why? Robots — built by Nvidia.
See More Headlines

OM Stock Analysis - Frequently Asked Questions

Outset Medical's stock was trading at $16.65 at the start of the year. Since then, OM shares have increased by 7.8% and is now trading at $17.95.
View the best growth stocks for 2025 here
.

Outset Medical, Inc. (NASDAQ:OM) announced its earnings results on Wednesday, May, 7th. The company reported ($3.66) earnings per share for the quarter, missing the consensus estimate of ($0.97) by $2.69. The business had revenue of $29.75 million for the quarter, compared to analyst estimates of $27.81 million. Outset Medical had a negative trailing twelve-month return on equity of 175.64% and a negative net margin of 112.57%.
Read the conference call transcript
.

Outset Medical shares reverse split on Thursday, March 20th 2025. The 1-15 reverse split was announced on Tuesday, March 18th 2025. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, March 19th 2025. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

Outset Medical (OM) raised $175 million in an IPO on Tuesday, September 15th 2020. The company issued 7,600,000 shares at $22.00-$24.00 per share. BofA Securities, Morgan Stanley and Goldman Sachs acted as the underwriters for the IPO and SVB Leerink and Stifel were co-managers.

Outset Medical's top institutional shareholders include Durable Capital Partners LP (48.41%), Alyeska Investment Group L.P. (47.37%), T. Rowe Price Investment Management Inc. (44.59%) and Woodline Partners LP (36.88%). Insiders that own company stock include Leslie Trigg, Steven S Williamson, Jean-Olivier Racine, Nabeel Ahmed, Marc Nash, John L Brottem, Martin Vazquez, Stacey L Porter and D Keith Grossman.
View institutional ownership trends
.

Shares of OM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Outset Medical investors own include Pinterest (PINS), Shopify (SHOP), Trade Desk (TTD), Fiverr International (FVRR), Teladoc Health (TDOC), Lemonade (LMND) and

Company Calendar

Last Earnings
5/07/2025
Today
5/24/2025
Next Earnings (Estimated)
8/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Electromedical equipment
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:OM
Fax
N/A
Employees
520
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$27.00
High Stock Price Target
$45.00
Low Stock Price Target
$15.00
Potential Upside/Downside
+50.4%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-172,800,000.00
Net Margins
-112.57%
Pretax Margin
-122.32%

Debt

Sales & Book Value

Annual Sales
$115.27 million
Price / Cash Flow
N/A
Book Value
$2.45 per share
Price / Book
7.33

Miscellaneous

Free Float
51,502,000
Market Cap
$318.11 million
Optionable
Not Optionable
Beta
1.90
7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report

This page (NASDAQ:OM) was last updated on 5/24/2025 by MarketBeat.com Staff
From Our Partners